CDC5L and breast carcinoma: We propose that as an effector of EIF4A3, CDC5L is regulated by EIF4A3 and that EIF4A3 can bind to its mRNA, which in turn affects the expression of downstream CyclinD1 and promotes the proliferation of breast cancer cells.